Concepts (160)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 2 | 19 | 2021 | 1362 | 2.090 |
Why?
|
| Hypoglycemic Agents | 12 | 2022 | 586 | 0.990 |
Why?
|
| Diabetes Mellitus, Type 1 | 8 | 2023 | 830 | 0.930 |
Why?
|
| Insulin Resistance | 5 | 2021 | 731 | 0.880 |
Why?
|
| Hypoglycemia | 4 | 2022 | 213 | 0.670 |
Why?
|
| Metformin | 4 | 2020 | 378 | 0.650 |
Why?
|
| Hyperglycemia | 4 | 2022 | 333 | 0.630 |
Why?
|
| Blood Glucose | 14 | 2023 | 1244 | 0.560 |
Why?
|
| Health Services Accessibility | 1 | 2020 | 761 | 0.490 |
Why?
|
| Insulin | 7 | 2022 | 1454 | 0.440 |
Why?
|
| Medication Adherence | 3 | 2020 | 492 | 0.290 |
Why?
|
| Adolescent | 22 | 2023 | 31252 | 0.290 |
Why?
|
| Evidence-Based Medicine | 1 | 2011 | 1085 | 0.260 |
Why?
|
| Puberty | 1 | 2021 | 104 | 0.200 |
Why?
|
| Wearable Electronic Devices | 1 | 2022 | 105 | 0.190 |
Why?
|
| Child | 18 | 2022 | 29154 | 0.170 |
Why?
|
| Vulnerable Populations | 1 | 2020 | 167 | 0.170 |
Why?
|
| Menstruation Disturbances | 1 | 2018 | 22 | 0.160 |
Why?
|
| Age of Onset | 1 | 2020 | 827 | 0.160 |
Why?
|
| Insurance Coverage | 1 | 2020 | 256 | 0.160 |
Why?
|
| Medicaid | 1 | 2020 | 279 | 0.150 |
Why?
|
| Nutrition Surveys | 1 | 2017 | 295 | 0.140 |
Why?
|
| Insulin Infusion Systems | 3 | 2022 | 53 | 0.140 |
Why?
|
| Quality of Life | 2 | 2011 | 4532 | 0.140 |
Why?
|
| Glucagon | 1 | 2016 | 196 | 0.140 |
Why?
|
| Diabetic Nephropathies | 1 | 2017 | 183 | 0.130 |
Why?
|
| Gastrointestinal Agents | 1 | 2016 | 108 | 0.130 |
Why?
|
| Diabetic Cardiomyopathies | 1 | 2014 | 21 | 0.120 |
Why?
|
| Humans | 30 | 2023 | 261506 | 0.120 |
Why?
|
| Diabetes Mellitus | 1 | 2022 | 1054 | 0.120 |
Why?
|
| Depression | 4 | 2016 | 1715 | 0.120 |
Why?
|
| Diabetic Angiopathies | 1 | 2014 | 78 | 0.110 |
Why?
|
| Family | 2 | 2009 | 736 | 0.110 |
Why?
|
| Cohort Studies | 3 | 2020 | 9244 | 0.110 |
Why?
|
| Metabolic Syndrome | 1 | 2015 | 353 | 0.100 |
Why?
|
| Heart Atria | 1 | 2014 | 352 | 0.100 |
Why?
|
| Blood Glucose Self-Monitoring | 2 | 2023 | 108 | 0.100 |
Why?
|
| Self Care | 2 | 2009 | 224 | 0.090 |
Why?
|
| Cysteine | 1 | 2010 | 214 | 0.090 |
Why?
|
| Body Mass Index | 4 | 2021 | 2203 | 0.090 |
Why?
|
| Heart Ventricles | 1 | 2014 | 846 | 0.080 |
Why?
|
| Male | 17 | 2023 | 123000 | 0.080 |
Why?
|
| Autoantibodies | 2 | 2023 | 576 | 0.080 |
Why?
|
| Glycine | 1 | 2010 | 289 | 0.080 |
Why?
|
| Glutathione | 1 | 2010 | 368 | 0.080 |
Why?
|
| Biomarkers | 1 | 2020 | 5047 | 0.080 |
Why?
|
| Female | 18 | 2023 | 141928 | 0.080 |
Why?
|
| Parents | 1 | 2015 | 998 | 0.080 |
Why?
|
| Obesity, Morbid | 1 | 2010 | 224 | 0.080 |
Why?
|
| Urban Health Services | 1 | 2007 | 37 | 0.080 |
Why?
|
| Risk Factors | 5 | 2021 | 17523 | 0.080 |
Why?
|
| Parent-Child Relations | 1 | 2009 | 257 | 0.080 |
Why?
|
| Young Adult | 3 | 2021 | 21445 | 0.070 |
Why?
|
| Cardiovascular Diseases | 3 | 2015 | 2195 | 0.070 |
Why?
|
| Patient Compliance | 1 | 2011 | 667 | 0.070 |
Why?
|
| Obesity | 3 | 2015 | 2884 | 0.070 |
Why?
|
| Magnesium Sulfate | 1 | 2006 | 39 | 0.070 |
Why?
|
| Pregnancy, Multiple | 1 | 2006 | 45 | 0.070 |
Why?
|
| Glucose | 2 | 2023 | 1248 | 0.070 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2006 | 84 | 0.070 |
Why?
|
| Pilot Projects | 2 | 2020 | 2803 | 0.070 |
Why?
|
| United States | 2 | 2020 | 15433 | 0.070 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2009 | 2796 | 0.060 |
Why?
|
| Health Promotion | 1 | 2007 | 502 | 0.060 |
Why?
|
| Insulin, Regular, Human | 1 | 2022 | 12 | 0.060 |
Why?
|
| Social Support | 1 | 2005 | 560 | 0.050 |
Why?
|
| Accelerometry | 1 | 2022 | 63 | 0.050 |
Why?
|
| Health Behavior | 1 | 2007 | 603 | 0.050 |
Why?
|
| Adult | 5 | 2021 | 77950 | 0.050 |
Why?
|
| Islets of Langerhans | 1 | 2021 | 229 | 0.050 |
Why?
|
| Child, Preschool | 4 | 2022 | 16273 | 0.050 |
Why?
|
| Exercise | 1 | 2007 | 1183 | 0.040 |
Why?
|
| Diet | 1 | 2007 | 1440 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2009 | 4320 | 0.040 |
Why?
|
| Sex Hormone-Binding Globulin | 1 | 2018 | 40 | 0.040 |
Why?
|
| Dyslipidemias | 1 | 2021 | 235 | 0.040 |
Why?
|
| Aspartate Aminotransferases | 1 | 2018 | 153 | 0.040 |
Why?
|
| Machine Learning | 1 | 2020 | 319 | 0.040 |
Why?
|
| Electrocardiography | 1 | 2022 | 1145 | 0.040 |
Why?
|
| Pediatric Obesity | 1 | 2021 | 364 | 0.040 |
Why?
|
| Morbidity | 1 | 2017 | 397 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2020 | 1544 | 0.030 |
Why?
|
| Injections, Subcutaneous | 1 | 2016 | 334 | 0.030 |
Why?
|
| Binge-Eating Disorder | 1 | 2015 | 6 | 0.030 |
Why?
|
| Androgens | 1 | 2018 | 511 | 0.030 |
Why?
|
| Estradiol | 1 | 2018 | 748 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2021 | 12873 | 0.030 |
Why?
|
| Life Style | 1 | 2018 | 612 | 0.030 |
Why?
|
| Random Allocation | 1 | 2016 | 703 | 0.030 |
Why?
|
| Prevalence | 2 | 2015 | 3260 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 1 | 2017 | 602 | 0.030 |
Why?
|
| Atrial Function, Left | 1 | 2014 | 24 | 0.030 |
Why?
|
| Ventricular Dysfunction | 1 | 2014 | 33 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 14889 | 0.030 |
Why?
|
| Testosterone | 1 | 2018 | 619 | 0.030 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2014 | 112 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2018 | 2315 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2016 | 1225 | 0.030 |
Why?
|
| Drug Delivery Systems | 1 | 2016 | 669 | 0.030 |
Why?
|
| Gastrointestinal Hormones | 1 | 2010 | 26 | 0.020 |
Why?
|
| Body Weight | 1 | 2015 | 1293 | 0.020 |
Why?
|
| Gastric Bypass | 1 | 2010 | 81 | 0.020 |
Why?
|
| Bariatric Surgery | 1 | 2010 | 107 | 0.020 |
Why?
|
| Fatty Liver | 1 | 2010 | 235 | 0.020 |
Why?
|
| Asparaginase | 1 | 2009 | 184 | 0.020 |
Why?
|
| Age Factors | 2 | 2011 | 5377 | 0.020 |
Why?
|
| Daunorubicin | 1 | 2009 | 301 | 0.020 |
Why?
|
| Echocardiography | 1 | 2014 | 1182 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 4938 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 4971 | 0.020 |
Why?
|
| Physical Endurance | 1 | 2007 | 58 | 0.020 |
Why?
|
| Adolescent Behavior | 1 | 2009 | 230 | 0.020 |
Why?
|
| Muscle Strength | 1 | 2007 | 104 | 0.020 |
Why?
|
| Maternal Behavior | 1 | 2007 | 62 | 0.020 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2010 | 228 | 0.020 |
Why?
|
| Disease Progression | 1 | 2017 | 6682 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2021 | 37905 | 0.020 |
Why?
|
| Prednisone | 1 | 2009 | 984 | 0.020 |
Why?
|
| Calcitriol | 1 | 2006 | 127 | 0.020 |
Why?
|
| Urban Population | 1 | 2007 | 269 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2010 | 558 | 0.020 |
Why?
|
| Magnesium | 1 | 2006 | 160 | 0.020 |
Why?
|
| Alkaline Phosphatase | 1 | 2006 | 207 | 0.020 |
Why?
|
| Community Health Services | 1 | 2007 | 126 | 0.020 |
Why?
|
| Sex Factors | 1 | 2011 | 2139 | 0.020 |
Why?
|
| Family Health | 1 | 2007 | 325 | 0.020 |
Why?
|
| Hypertension | 1 | 2015 | 1503 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2009 | 629 | 0.020 |
Why?
|
| Health Education | 1 | 2007 | 309 | 0.020 |
Why?
|
| Minority Groups | 1 | 2007 | 322 | 0.020 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2010 | 421 | 0.020 |
Why?
|
| Vincristine | 1 | 2009 | 1511 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2007 | 597 | 0.020 |
Why?
|
| Bone Density Conservation Agents | 1 | 2006 | 198 | 0.020 |
Why?
|
| Texas | 2 | 2007 | 6311 | 0.020 |
Why?
|
| Survival Rate | 1 | 2017 | 12221 | 0.020 |
Why?
|
| Dexamethasone | 1 | 2009 | 1450 | 0.010 |
Why?
|
| Nuclear Family | 1 | 2003 | 55 | 0.010 |
Why?
|
| Time Factors | 1 | 2017 | 12926 | 0.010 |
Why?
|
| Bone and Bones | 1 | 2006 | 619 | 0.010 |
Why?
|
| Mental Disorders | 1 | 2010 | 862 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2009 | 1203 | 0.010 |
Why?
|
| Psychometrics | 1 | 2007 | 937 | 0.010 |
Why?
|
| Remission Induction | 1 | 2008 | 3569 | 0.010 |
Why?
|
| Radiography | 1 | 2006 | 1904 | 0.010 |
Why?
|
| Prognosis | 1 | 2020 | 21713 | 0.010 |
Why?
|
| Medical Records | 1 | 2003 | 415 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2015 | 32848 | 0.010 |
Why?
|
| Infant, Premature | 1 | 2006 | 787 | 0.010 |
Why?
|
| Calcium | 1 | 2006 | 1537 | 0.010 |
Why?
|
| Middle Aged | 2 | 2021 | 86204 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2007 | 1209 | 0.010 |
Why?
|
| Aged | 1 | 2021 | 70117 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2010 | 5542 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2007 | 5687 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2003 | 4744 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2006 | 8223 | 0.010 |
Why?
|
| Pregnancy | 1 | 2006 | 7573 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2009 | 10035 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2009 | 14289 | 0.000 |
Why?
|